文献
J-GLOBAL ID:201802279881158767
整理番号:18A2141261
J-SUPPORT 1604(J-FORCE)の試験計画:シスプラチンベースの高催吐性化学療法を受けている患者における化学療法誘発悪心および嘔吐の予防のためのオランザピン(5mg)+標準的3剤併用制吐療法を評価する無作為化二重盲検プラセボ対照第III相試験
Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy
著者 (14件):
HASHIMOTO Hironobu
(National Cancer Center Hospital)
,
ABE Masakazu
(Shizuoka Cancer Center)
,
YANAI Takako
(National Cancer Center Hospital)
,
YAMAGUCHI Takuhiro
(Tohoku Univ. Graduate School of Medicine)
,
ZENDA Sadamoto
(National Cancer Center Hospital East)
,
ZENDA Sadamoto
(National Cancer Center Hospital)
,
ZENDA Sadamoto
(J-SUPPORT)
,
UCHITOMI Yosuke
(National Cancer Center Hospital)
,
UCHITOMI Yosuke
(J-SUPPORT)
,
FUKUDA Haruhiko
(National Cancer Center Hospital)
,
MORI Mikio
(National Cancer Center Hospital)
,
IWASA Satoru
(National Cancer Center Hospital)
,
YAMAMOTO Noboru
(National Cancer Center Hospital)
,
OHE Yuichiro
(National Cancer Center Hospital, Tokyo, JPN)
資料名:
Japanese Journal of Clinical Oncology (Web)
(Japanese Journal of Clinical Oncology (Web))
巻:
48
号:
10
ページ:
950-952 (WEB ONLY)
発行年:
2018年10月
JST資料番号:
U1085A
ISSN:
1465-3621
資料種別:
逐次刊行物 (A)
記事区分:
解説
発行国:
イギリス (GBR)
言語:
英語 (EN)